Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP664443.RAQzIhbeGDq1ta-lYQEveyiyXfAl-hg9Ke5g45erR53aQ130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664443.RAQzIhbeGDq1ta-lYQEveyiyXfAl-hg9Ke5g45erR53aQ130_provenance.
• NP864777.RAj14au6iKIPAJIAtoWFLgxUqM6KjxZlLyBkDfFGZm6dI130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864777.RAj14au6iKIPAJIAtoWFLgxUqM6KjxZlLyBkDfFGZm6dI130_provenance.
• assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708069.RA5_GzSz0cC-YNUsK6d_4tH2vaGXSPdH94lW478OrmtEw130_provenance.
• NP740952.RAP6WZicDojjT2yG4v-6ZwrleM1Jr2E-0zFjk6mSCbLZw130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740952.RAP6WZicDojjT2yG4v-6ZwrleM1Jr2E-0zFjk6mSCbLZw130_provenance.
• NP438032.RAprHiO4Ue2t-rOnWaoD5y66veNcVmXs_xXVR45AS8mCI130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438032.RAprHiO4Ue2t-rOnWaoD5y66veNcVmXs_xXVR45AS8mCI130_provenance.
• NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327112.RAtbZUq6kNOCh0zrZzZiy5fVHqZE4sqXuUe5vCPKx6LPw130_provenance.
• NP1327118.RAl2HIhFMikYabcbtJ33o-zoJTbOyIgCk9A9bFBVTq-64130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327118.RAl2HIhFMikYabcbtJ33o-zoJTbOyIgCk9A9bFBVTq-64130_provenance.
• NP438165.RAHBmECBX5_dmlgxk37po5aS9TguTHd0Okw-xDUZ9PAgE130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438165.RAHBmECBX5_dmlgxk37po5aS9TguTHd0Okw-xDUZ9PAgE130_provenance.
• NP1327120.RAGvlT2_1lJlieO-fLlA1wunq_5eLHQmOKF-SMelfp0tA130_assertion description "[The highest proportion of the GSTM1(-) genotype was found in patients diagnosed with adenocarcinoma (63%, 29/46) and small cell carcinoma (72%, 21/29) before 66 years of age and among female squamous cell carcinoma patients (79%, 15/19).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327120.RAGvlT2_1lJlieO-fLlA1wunq_5eLHQmOKF-SMelfp0tA130_provenance.